News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
Get the Bio<sup>M</sup>Â Discount for the 3rd ICPO Theranostics Virtual Summit 202608.07.2026Get the BioMÂ Discount for the 3rd ICPO Theranostics Virtual Summit 2026We are delighted to offer our Bavarian Biotech Community a special BioM Discount for the 3rd ICPO Theranostics Virtual Summit 2026, taking place on Nov 12 & 13, 2026 as an online event. The… -
TUM develops affordable high-tech glove for people with hand paralysis08.07.2026TUM develops affordable high-tech glove for people with hand paralysisResearchers at the Technical University of Munich (TUM) have developed a soft, pneumatic hand exoskeleton that can help people with paralysis regain the ability to grasp objects. Combining… -
TUM researchers develop electrically controlled DNA origami switch07.07.2026TUM researchers develop electrically controlled DNA origami switchThe development of programmable molecular machines has taken an important step forward. Researchers at the Technical University of Munich (TUM) have developed an exceptionally reliable and… -
m<sup>4</sup> award winner smartbax expands funding to 6.3 million euros for the development of antibiotics against multidrug-resistant bacteria06.07.2026m4 award winner smartbax expands funding to 6.3 million euros for the development of antibiotics against multidrug-resistant bacteriaMunich-based m4 Award winner smartbax has successfully expanded its pre-Series A funding round to a total of 6.3 million euros. With the additional capital, the biotech company plans to… -
Three ERC Proof of Concept Grants awarded to FAU: AI for disease detection, biocompatible electrodes and nanoparticle-based antibiotics06.07.2026Three ERC Proof of Concept Grants awarded to FAU: AI for disease detection, biocompatible electrodes and nanoparticle-based antibioticsMajor success: Three researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have been awarded Proof of Concept (PoC) Grants by the European Research Council (ERC): medical… -
Austria and Galicia as Partner Regions of BayOConnect 2026 – European Collaboration in Action03.07.2026Austria and Galicia as Partner Regions of BayOConnect 2026 – European Collaboration in ActionWith Austria and Galicia as this year’s partner regions, BioM welcomed two partner regions at its BayOConnect 2026 event that demonstrated why European collaboration is more important than… -
BayOConnect 2026: Bio<sup>M</sup> shows at its biotech conference how Europe's innovations can be brought to market more quickly02.07.2026BayOConnect 2026: BioM shows at its biotech conference how Europe's innovations can be brought to market more quicklyBayOConnect 2026 brought together leading players from the biotechnology, pharmaceutical, scientific, investment, and political sectors from across Europe in Munich.Under the theme “Driving… -
LMU Munich receives ERC Proof-of-Concept Grant for data-driven nanocarrier development of RNA drugs02.07.2026LMU Munich receives ERC Proof-of-Concept Grant for data-driven nanocarrier development of RNA drugsOlivia Merkel, Professor of Drug Delivery in the Department of Pharmacy at Ludwig-Maximilians-Universität München, has received a Proof-of-Concept Grant from the European Research Council,… -
Mallia secures €3 million financing to accelerate commercial expansion of the 8T3 Essentials Line01.07.2026Mallia secures €3 million financing to accelerate commercial expansion of the 8T3 Essentials LineMallia Innovations GmbH, the holding company strategically driving the development and commercialization of biopharmaceutical therapies targeting hair loss and wound healing as well as… -
Forschende der Uni Bayreuth machen künstliche Proteine zu leistungsfähigen Enzymen30.06.2026Forschende der Uni Bayreuth machen künstliche Proteine zu leistungsfähigen EnzymenEnzymes are considered key to sustainable chemistry. Despite major advances in protein design, however, it has so far been difficult to create artificial enzymes from scratch. A research team…